Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Zentalis Pharmaceuticals (ZNTL) Return on Sales (2024 - 2025)

Zentalis Pharmaceuticals has reported Return on Sales over the past 2 years, most recently at 0.06% for Q3 2025.

  • For Q3 2025, Return on Sales fell 1.0% year-over-year to 0.06%; the TTM value through Sep 2025 reached 0.06%, down 1.0%, while the annual FY2024 figure was 0.02%, N/A changed from the prior year.
  • Return on Sales for Q3 2025 was 0.06% at Zentalis Pharmaceuticals, up from 0.06% in the prior quarter.
  • Over five years, Return on Sales peaked at 0.0% in Q1 2024 and troughed at 0.08% in Q1 2025.